作者: Frank Pourcine , Sebastien Jochmans , Vincent Dubée , Mehran Monchi , Sylvain Diamantis
DOI: 10.1155/2020/2093468
关键词:
摘要: Introduction Treatment of Haemophilus influenzae (Hi) pneumonia is on concern because resistance to amoxicillin largely diffused. This study describes the evolution and amoxicillin/clavulanic acid (AMC) in Hi isolates characteristics patients with severe pneumonia. Methods A monocentric retrospective observational including from 2008 2017 hospitalized ICU. Evolution AMC susceptibility was showed. Characteristics were compared Streptococcus pneumoniae (Sp) pneumonia, as reference. Risk factors for investigated. Results Overall, 113 132 Sp included. The percentages among strains decreased over years (from 10% 2008-2009 0% 2016-2017) while remained stable at 20%. Also, resistant 25% 3%). Patients experienced higher prevalence bronchitis (18% vs. 8%, p=0.02, chronic obstructive pulmonary disease (43% 30% p=0.03), HAP 7%, p=0.01, ventilator-associated (27% 17%, p=0.04, longer duration mechanical ventilation (8 days 6 days, p=0.04) than had more frequently local complications (17% p=0.03). De-escalation antibiotics frequent (67% 53%, No risk associated Conclusions Amoxicillin time, but no detected. extremely low, suggesting that could be used empiric treatment well other molecules, namely, cephalosporins. comorbidities diseases